ExodusPoint Capital Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Buy |
82,977
+67,922
| +451% | +$1.02M | 0.01% | 843 |
|
|
2025
Q1 | $243K | Sell |
15,055
-1,636
| -10% | -$26.4K | ﹤0.01% | 1208 |
|
|
2024
Q4 | $389K | Buy |
16,691
+6,958
| +71% | +$162K | ﹤0.01% | 1109 |
|
|
2024
Q3 | $286K | Buy |
+9,733
| New | +$286K | ﹤0.01% | 1272 |
|
|
2024
Q2 | – | Sell |
-24,472
| Closed | -$928K | – | 1826 |
|
|
2024
Q1 | $928K | Sell |
24,472
-1,738
| -7% | -$65.9K | 0.01% | 862 |
|
|
2023
Q4 | $564K | Buy |
+26,210
| New | +$564K | ﹤0.01% | 935 |
|
|
2023
Q2 | – | Sell |
-4,699
| Closed | -$34K | – | 2127 |
|
|
2023
Q1 | $34K | Buy |
4,699
+489
| +12% | +$3.54K | ﹤0.01% | 1580 |
|
|
2022
Q4 | $47K | Buy |
+4,210
| New | +$47K | ﹤0.01% | 1496 |
|
|
2019
Q2 | – | Sell |
-430
| Closed | -$87K | – | 1292 |
|
|
2019
Q1 | $87K | Buy |
+430
| New | +$87K | 0.01% | 609 |
|